Keyword: Genentech

Micro cap anti-infective biotech Aridis Pharmaceuticals has gained a new chief medical officer in the form of former Takeda Vaccines exec Paul Mendelm

After a series of major exits from its C-suite including the exit of Chief Medical Officer Andrew Cheng last fall, Gilead now has a new CMO.

With new data exploring lung cancer biomarkers, Roche says that DNA blood tests could soon replace tissue biopsies for picking targeted treatments.

Takeda’s cytomegalovirus drug beat Roche’s Valcyte at clearing the virus in patients who had undergone an organ transplant or stem cell transplant.

Smaller biotechs are continuing their biopharma hiring spree as two startups nab some big names for their aspiring cancer drug research.

Opthea tested its drug in combination with Lucentis, finding that the combo bested Lucentis alone at improving vision and reducing scarring in the retina.

Levi Garraway is set to take up one of the biggest hot seats in biopharma when he becomes the next chief medical officer at Roche.

The mezzanine round will fund ORIC's lead asset through phase 1b and into phase 2 and move a second program into the clinic.

Foundation Medicine brought on Priti Hegde to be chief scientific officer and oversee its clinical product development and cancer genomics work.

The termination of the clinical trial and molecule follows slower-than-expected progress for RG6174.